Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
25.35B | 23.37B | 22.67B | 21.81B | 0.00 | Gross Profit |
9.70B | 8.98B | 9.27B | 8.93B | 0.00 | EBIT |
890.00M | 484.00M | 861.00M | 798.00M | 404.00M | EBITDA |
1.58B | 1.19B | 1.52B | 1.56B | 1.32B | Net Income Common Stockholders |
599.00M | 310.00M | 561.00M | 533.00M | 404.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.53B | 2.20B | 2.83B | 2.65B | 1.99B | Total Assets |
16.39B | 15.35B | 15.66B | 15.12B | 14.23B | Total Debt |
812.00M | 952.00M | 951.00M | 1.16B | 1.49B | Net Debt |
-1.71B | -1.24B | -1.88B | -1.48B | -499.00M | Total Liabilities |
6.86B | 6.26B | 6.72B | 6.54B | 6.04B | Stockholders Equity |
9.54B | 9.09B | 8.95B | 8.57B | 8.19B |
Cash Flow | Free Cash Flow | |||
747.00M | -212.00M | 756.00M | 1.34B | 610.00M | Operating Cash Flow |
975.00M | 493.00M | 1.10B | 1.97B | 1.14B | Investing Cash Flow |
-233.00M | -678.00M | -354.00M | -635.00M | -534.00M | Financing Cash Flow |
-414.00M | -450.00M | -562.00M | -671.00M | -337.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥14.08B | 4.85 | 3.40% | 8.95% | 35.94% | ||
71 Outperform | ¥10.30B | 9.34 | 2.22% | 2.08% | -17.38% | ||
68 Neutral | ¥4.24B | 3.62 | 1.88% | 0.86% | 17.26% | ||
65 Neutral | $8.88B | 15.05 | 4.75% | 203.76% | 3.54% | -2.50% | |
61 Neutral | ¥8.70B | 30.13 | 0.91% | 6.33% | 40.87% | ||
59 Neutral | ¥13.55B | 29.59 | 1.28% | 3.51% | -23.54% |